Effect of Single Dose NP001 on Blood Markers of Inflammation in Individuals With Mild-to-Moderate Alzheimer's Disease
Phase of Trial: Phase I
Latest Information Update: 29 Oct 2018
At a glance
- Drugs NP-001 (Primary)
- Indications Alzheimer's disease
- Focus Biomarker; Pharmacodynamics
- 18 Oct 2018 Status changed from recruiting to discontinued.
- 31 Aug 2018 Biomarkers information updated
- 31 May 2018 Planned End Date changed from 31 Dec 2017 to 31 Jul 2018.